Argon Medical Devices is latest US health firm to get dose of Chinese funds
New York
SHANDONG Weigao Group Medical Polymer Co agreed to buy closely held Argon Medical Devices Inc for US$850 million, continuing a string of deals by Chinese companies seeking to gain a foothold in the US healthcare market.
Shandong Weigao made the acquisition through a joint venture with a private equity-backed firm that will control 10 per cent, according to a statement to the Hong Kong stock exchange. The venture will fund US$420 million of the purchase with debt, the company said without identifying the private-equity firm.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Chinese tariffs could leave cognac makers with too much brandy
Holiday Inn owner IHG’s Q1 revenue up 2.6%, leisure travel demand remains strong
WSJ moves Asia headquarters from Hong Kong to Singapore
South Korea to slap fines on food suppliers for ‘shrinkflation’
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Live Nation’s revenue beats estimates as boom in concerts drive ticket sales